Acute Anterior Ischemic Optic Neuropathy associated with Giant Cell Arteritis in Horton's Disease research hub

French prospective open label phase II randomized non-comparative study of SC tocilizumab associated with IV pulse steroid versus IV pulse steroid alone for the treatment of acute anterior ischemic optic neuropathy associated with giant cell arteritis. (TOCIAION)

This study looks at a new way to treat sudden vision loss from a condition called giant cell arteritis (GCA). It compares standard treatment with a new drug, tocilizumab, to see if the new drug can help improve eyesight more effectively.